Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Spectrum to Present at Two Upcoming Investor Conferences in September

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, announced today that management will present an overview of the company's business strategy and development-stage programs at two upcoming virtual investor conferences:

Rodman & Renshaw 22nd Annual Global Investment Conference, Sponsored by H.C. Wainwright, Monday, September 14, 2020 at 2:00 p.m. ET.
Cantor Virtual Global Healthcare Conference, Thursday, September 17, 2020 at 10:40 a.m. ET.
A live webcast of the presentations will be available from the Investor Relations section of the company’s website at http://investor.sppirx.com/events-and-presentations with a replay available shortly after each event.

I was wondering if the only news we hear from Spectrum till the Nov Quarterly was about Rolontis approval in October. I dearly want to hear about the status of pozi's pre NDA meeting w the FDA i.e. did they have it. Once they have the meeting the FDA releases the official meeting minutes within 30 days. Of course, Spectrum will know if they can go ahead and submit a NDA at the meeting itself but the minutes makes it etched in stone. So hopefully we hear about what's going on w pozi at these Investment CCs.